BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37288570)

  • 1. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial.
    King JB; Derington CG; Herrick JS; Jacobs JA; Zheutlin AR; Conroy MB; Cushman WC; Bress AP
    Hypertension; 2023 Aug; 80(8):1749-1758. PubMed ID: 37288570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial.
    Derington CG; Bress AP; Moran AE; Weintraub WS; Herrick JS; Cushman WC; Kronish IM; Stults B; Shimbo D; Muntner P; Greene T; Bates JT; Chang TI; Katz LA; Rehman SU; Roumie CL; Tamariz L; King JB
    Hypertension; 2023 Mar; 80(3):590-597. PubMed ID: 36519451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
    Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020.
    Derington CG; Bress AP; Herrick JS; Jacobs JA; Zheutlin AR; Berchie RO; Conroy MB; Cushman WC; King JB
    J Am Heart Assoc; 2023 Jun; 12(11):e028573. PubMed ID: 37158068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
    JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Pressure Intervention and Control in SPRINT.
    Cushman WC; Ringer RJ; Rodriguez CJ; Evans GW; Bates JT; Cutler JA; Hawfield A; Kitzman DW; Nasrallah IM; Oparil S; Nord J; Papademetriou V; Servilla K; Van Buren P; Whelton PK; Whittle J; Wright JT;
    Hypertension; 2022 Sep; 79(9):2071-2080. PubMed ID: 35766041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial).
    Jacobs JA; Derington CG; Zheutlin AR; King JB; Cohen JB; Bucheit J; Kronish IM; Addo DK; Morisky DE; Greene TH; Bress AP
    J Am Heart Assoc; 2024 Feb; 13(3):e031574. PubMed ID: 38240275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
    JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations.
    Rocco MV; Comeau ME; Marion MC; Freedman BI; Hawfield AT; Langefeld CD;
    Hypertension; 2020 Dec; 76(6):1717-1724. PubMed ID: 33100049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
    Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
    JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM;
    Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.